UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012208 |
|---|---|
| Receipt number | R000014275 |
| Scientific Title | A phase II trial of pertuzumab and trastuzumab in combination with capecitabine in patients with metastatic breast cancer who received prior trastuzumab combination chemotherapy. |
| Date of disclosure of the study information | 2013/11/05 |
| Last modified on | 2016/05/16 11:50:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/04 18:33:08 | ||
| 2 | Update | 2013/11/04 20:49:34 | Classification by specialty Narrative objectives1 |
|
| 3 | Update | 2013/11/04 20:50:30 | Public title Acronym |
|
| 4 | Update | 2016/05/16 11:50:39 | Recruitment status |
